Marketwatch Insider trading: Sebi imposes Rs 22 cr fine on Aurobindo Pharma, promoters, related entities Admin September 23, 2019 The probe found that the promoter entities traded in the scrip of APL based on unpublished price sensitive information. – Stocks-Markets-Economic Times Share on Facebook Tweet it Pin it Share it Email
